Literature DB >> 6478303

Two epizootics of lymphocytic choriomeningitis virus occurring in laboratory mice despite intensive monitoring programs.

A L Smith, F X Paturzo, E P Gardner, S Morgenstern, G Cameron, H Wadley.   

Abstract

Two epizootics of lymphocytic choriomeningitis virus in mice occurred within two months in one research facility consisting of several widely separated rooms. These outbreaks developed despite intensive institutional monitoring policies designed to prevent introduction and spread of lymphocytic choriomeningitis virus. Evidence derived from serological and virological assays and interviews with the concerned investigators suggested that a single transplantable tumor carried in mice may have been responsible for spread of the virus. However, the tumor was not contaminated with lymphocytic choriomeningitis virus at the time of its introduction into the mouse facility. The origin of the virus responsible for the outbreaks was not definitively established although data supported an hypothesis that the virus was introduced into the research facility by a wild or feral mouse. Virus spread from infected mice to humans did not occur, as measured by serological tests. However, a large and valuable animal facility was depopulated for safety reasons. Absorption of sera with lymphocytic choriomeningitis virus antigen proved a necessary and reliable method for confirming specificity of lymphocytic choriomeningitis virus fluorescence-positive reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478303      PMCID: PMC1236074     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  8 in total

1.  Public Health Weekly Reports for APRIL 28, 1939.

Authors: 
Journal:  Public Health Rep       Date:  1939-04-28       Impact factor: 2.792

Review 2.  Laboratory-associated infections: incidence, fatalities, causes, and prevention.

Authors:  R M Pike
Journal:  Annu Rev Microbiol       Date:  1979       Impact factor: 15.500

3.  An immunofluorescence test for detection of serum antibody to rodent coronaviruses.

Authors:  A L Smith
Journal:  Lab Anim Sci       Date:  1983-04

4.  Evidence of infection by viruses in small British field rodents.

Authors:  C Kaplan; T D Healing; N Evans; L Healing; A Prior
Journal:  J Hyg (Lond)       Date:  1980-04

5.  Serological diagnosis in children infected prenatally with lymphocytic choriomeningitis virus.

Authors:  M M Sheinbergas; V J Lewis; W L Thacker; V V Verikiene
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

6.  Recent outbreaks of lymphocytic choriomeningitis in the United States of America.

Authors:  M B Gregg
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

7.  Laboratory diagnosis of lymphocytic choriomeningitis.

Authors:  J Hotchin; E Sikora
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

8.  Murine lymphocytic choriomeningitis: the history of a natural cross-infection from wild to laboratory mice.

Authors:  H H Skinner; E H Knight; R Grove
Journal:  Lab Anim       Date:  1977-10       Impact factor: 2.471

  8 in total
  3 in total

Review 1.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

2.  Comparison of isolation in cell culture with conventional and modified mouse antibody production tests for detection of murine viruses.

Authors:  M de Souza; A L Smith
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Trace-forward investigation of mice in response to lymphocytic choriomeningitis virus outbreak.

Authors:  Laura Edison; Barbara Knust; Bret Petersen; Julie Gabel; Craig Manning; Cherie Drenzek; Ute Ströher; Pierre E Rollin; Douglas Thoroughman; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.